---
DrugClass: "[[Antiparkinson]]"
SubClass: "[[COMT Inhibitors]]"
DrugClassContra: "[[COMT Inhibitors#Contraindications]]"
DrugClassAdverse: "[[COMT Inhibitors#Adverse Reactions]]"
SecondaryDrugClass: 
SecondarySubClass: 
BrandName: Comtan
Chapter: "27"
KindleLinkChap: "[Chapter 27](kindle://book?action=open&asin=B09FRF11YJ&location=14154)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
---
```smiles
CCN(CC)C(=O)/C(=C/C1=CC(=C(C(=C1)O)O)[N+](=O)[O-])/C#N
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`

### Dosage & Usage
As adjunct to [[levodopa]]/ [[carbidopa]] in Parkinson disease
200â€“ 1600 mg/ day orally

### Contraindications
See `= this.DrugClassContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
[[Dyskinesia]], [[hyperkinesia]], nausea, diarrhea, urine discoloration

### Interactions

`= this.ChemLink+this.file.name`

 